Clinical trial
Study of RADPLAT and Tarceva in Locally Advanced Head and Neck Squamous Cell…
NCT00304278 · Southern Illinois University, Other · Completed
Key facts
| NCT number | NCT00304278 |
|---|---|
| Title | Study of RADPLAT and Tarceva in Locally Advanced Head and Neck Squamous Cell Carcinoma (SCCA) |
| Official title | Phase II Study of RADPLAT and Tarceva in Locally Advanced Head and Neck Squamous Cell Carcinoma (SCCA) |
| Lead sponsor | Southern Illinois University, Other |
| Collaborators | Genentech, Inc. Industry OSI Pharmaceuticals |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug, Radiation |
| Interventions | Erlotinib (Tarceva), Intra-arterial Cisplatin (PLAT), Radiation Therapy (RAD) |
| Enrollment | 21 |
| Start date | Mar 1, 2006 |
| Primary completion | May 1, 2015 |
| Completion | Dec 1, 2015 |
| First posted | Mar 17, 2006 |
| Last update posted | Jul 27, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: